Skip to content
10-K

Annual Report

TherapeuticsMD, Inc. TXMD

0001013762-25-003442

← back to feed
Filed
Mar 27, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 20, 2025 11.57M sh
Cash And Equivalents FY 2024 · Dec 31, 2024 $5.06M
Cash And Equivalents FY 2024 · Dec 31, 2023 $4.33M
Sga Expense FY 2024 · Dec 31, 2024 $4.74M
Sga Expense FY 2024 · Dec 31, 2023 $8.9M
Shares Diluted restated FY 2024 · Dec 31, 2023 10.44K sh
Current Liabilities FY 2024 · Dec 31, 2023 $6.85M
Total Liabilities FY 2024 · Dec 31, 2023 $14.02M
Current Assets FY 2024 · Dec 31, 2023 $11.8M
Total Assets FY 2024 · Dec 31, 2023 $43.31M
Eps Diluted restated FY 2024 · Dec 31, 2023 −$0.99
Eps Basic restated FY 2024 · Dec 31, 2023 −$0.99
Net Income FY 2024 · Dec 31, 2023 −$10.28M
Operating Income FY 2024 · Dec 31, 2023 −$8.52M
Stockholders Equity FY 2024 · Dec 31, 2022 $35.14M